USL311 is an orally active CXCR4 inhibitor. USL311 blocks the activity of the CXCR4 receptor. USL311 is applicable to research related to various cancers including breast cancer, bladder cancer, colon cancer, rectal cancer, liver cancer and glioblastoma[1][2].
Molecular Weight:
422.57
Purity:
99.97
CAS Number:
[1373268-67-7]
Formula:
C24H34N6O
Target:
CXCR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted